⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15688606 | 1.00 | — | — | |
| SCHEMBL16395565 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL25214533 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL16395482 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL11635122 | 0.96 | — | — | |
| SCHEMBL14081835 | 0.72 | — | — | |
| SCHEMBL21846682 | 0.72 | — | — | |
| SCHEMBL24907240 | 0.72 | — | — | |
| SCHEMBL20385283 | 0.72 | — | — | |
| SCHEMBL18627013 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111727185-A | Substituted N-heterocyclyl-and N-heteroaryltetrahydropyrimidines and their salts and their use as herbicidal active substances | 拜耳公司 | 2020-09-29 | — | — | CN | claimed |
| US-12503475-B2 | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists | CENTESSA PHARMACEUTICALS (UK) LIMITED (GB) | 2025-12-23 | — | — | US | disclosed |
| US-20240027902-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| CN-117209393-A | Preparation method of aromatic cyclopropyl formamide | 泓博智源(开原)药业有限公司 | 2023-12-12 | — | — | CN | disclosed |
| US-20230365511-A1 | Antiviral Pyrazolopiridinone Compounds | NOVARTIS AG (CH) | 2023-11-16 | — | — | US | disclosed |
| US-20230305393-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
| US-20230305394-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
| US-20230271973-A1 | BICYCLIC-HETEROCYCLE DERIVATIVES AND THEIR USES AS OREXIN-2 RECEPTOR AGONISTS | CENTESSA PHARMACEUTICALS (OREXIA) LIMITED (GB) | 2023-08-31 | — | — | US | disclosed |
| US-20230271973-A1 | BICYCLIC-HETEROCYCLE DERIVATIVES AND THEIR USES AS OREXIN-2 RECEPTOR AGONISTS | CENTESSA PHARMACEUTICALS (OREXIA) LIMITED (GB) | 2023-08-31 | — | — | US | disclosed |
| CN-116583502-A | Bicyclic-heterocyclic derivatives and their use as orexin-2 receptor agonists | 欧瑞夏治疗有限公司 | 2023-08-11 | — | — | CN | disclosed |
| US-20120171245-A1 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-07-05 | — | — | US | disclosed |
| WO-2012062703-A1 | METHOD FOR PREPARING 2,2-DIFLUOROETHYLAMINE STARTING FROM PROP-2-EN-1-AMINE | BAYER CROPSCIENCE AG (DE) | 2012-05-18 | — | — | WO | disclosed |
| EP-2431377-A1 | Modified L-nucleic acids | Noxxon Pharma AG (DE) | 2012-03-21 | — | — | EP | disclosed |
| WO-2011069994-A1 | METHOD FOR PRODUCING 2,2-DIFLUOROETHYLAMINE AND SALTS THEREOF, STARTING WITH DIFLUOROACETONE NITRILE | BAYER CROPSCIENCE AG (DE) | 2011-06-16 | — | — | WO | disclosed |
| WO-2011042376-A2 | METHOD FOR PRODUCING 2,2-DIFLUOROETHYLAMINE BY HYDROGENATING 1,1-DIFLUORO-2-NITROETHANE | BAYER CROPSCIENCE AG (DE) | 2011-04-14 | — | — | WO | disclosed |
| JP-2011026260-A | PROTECTED 2-FLUOROPROPYLAMINE HAVING LEAVING GROUP AT 3-POSITION OR PROTECTED N-ALKYL-2-FLUOROPROPYLAMINE HAVING LEAVING GROUP AT 3-POSITION | CENTRAL GLASS CO LTD | 2011-02-10 | — | — | JP | disclosed |
| WO-2011013635-A1 | PROTECTED 2-FLUOROPROPYLAMINE HAVING LEAVING GROUP AT 3-POSITION OR PROTECTED N-ALKYL-2-FLUOROPROPYLAMINE HAVING LEAVING GROUP AT 3-POSITION | セントラル硝子株式会社 (JP) | 2011-02-03 | — | — | WO | disclosed |
| US-7781396-B2 | Peptides directed for diagnosis and treatment of amyloid-associated disease | TEL AVIV UNIVERSITY FUTURE TECHNOLOGY DEVELOPMENT L.P. (IL) | 2010-08-24 | — | — | US | disclosed |
| WO-2010022125-A1 | ETHYNYL-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS | SCHERING CORPORATION (US) | 2010-02-25 | — | — | WO | disclosed |
| WO-2009036901-A1 | METHOD FOR PRODUCING 2,2-DIFLUOROETHYLAMINE DERIVATIVES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AG (DE) | 2009-03-26 | — | — | WO | disclosed |